Simplex Trading
BHVN

Simplex Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Simplex Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-212,000
Closed -$32M – 11194
2022
Q3 		$32M Buy
212,000
+169,600
+400% +$25.1M 0.04% 360
2022
Q2 		$6.18M Sell
42,400
-38,000
-47% -$4.85M 0.01% 1028
2022
Q1 		$9.53M Sell
80,400
-29,200
-27% -$3.64M 0.01% 863
2021
Q4 		$15.1M Buy
109,600
+107,900
+6,347% +$13.7M 0.02% 610
2021
Q3 		$169K Hold
1,700
– – ﹤0.01% 5864
2021
Q2 		$165K Buy
1,700
+1,657
+3,853% +$134K ﹤0.01% 6004
2021
Q1 		$293K Sell
43
-702
-94% -$56.8K ﹤0.01% 4175
2020
Q4 		$6.38M Buy
745
+657
+747% +$55.7K 0.01% 820
2020
Q3 		$572K Sell
88
-4
-4% -$262 ﹤0.01% 2833
2020
Q2 		$672K Sell
92
-7
-7% -$373 ﹤0.01% 2551
2020
Q1 		$336K Sell
99
-203
-67% -$9.28K ﹤0.01% 3031
2019
Q4 		$1.64M Buy
302
+179
+146% +$8.86K ﹤0.01% 1649
2019
Q3 		$513K Sell
123
-469
-79% -$19.8K ﹤0.01% 2597
2019
Q2 		$2.59M Buy
592
+547
+1,216% +$30.8K 0.01% 1104
2019
Q1 		$231K Sell
45
-7
-13% -$302 ﹤0.01% 3449
2018
Q4 		$192K Buy
+52
New +$1.88K ﹤0.01% 3204
2018
Q3 		– Sell
-2
Closed -$7K – 8688
2018
Q2 		$7K Sell
2
-426
-100% -$13.5K ﹤0.01% 6589
2018
Q1 		$59K Buy
+428
New +$12.8K ﹤0.01% 2288

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Simplex Trading's BHVN Position: Q3 2022 in Review

Simplex Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 4,426 shares — an estimated $656K sold.

Simplex Trading first reported a position in BHVN in Q4 2017 and held it in 13 quarters. The position peaked at $2.38M in Q2 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Simplex Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 4,426 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $656K.
  • Simplex Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 13 quarters.
  • Simplex Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.38M in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.